ANGELA LIMPUS: Open Payments
NPI 1013229251 · OZARK, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Alkermes, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Omnipod, VIVITROL, Dexcom G6 Transmitter, QULIPTA, CAPLYTA, BREZTRI, AIRSUPRA, KISUNLA.
Industry payments across MO — which companies pay providers there.
